# OnCo record paper-aggarwal-plasma-genotyping-personalised-therapy-jama-oncol-2019 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-aggarwal-plasma-genotyping-personalised-therapy-jama-oncol-2019/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-aggarwal-plasma-genotyping-personalised-therapy-jama-oncol-2019" ;
  schema:name "Clinical implications of plasma-based genotyping with the delivery of personalized therapy in metastatic non-small cell lung cancer"@en ;
  schema:description "Adding a blood test to routine practice nearly doubled the number of patients found to have a treatable mutation, and a third of those tested by blood alone were spared a biopsy."@en ;
  schema:url <https://onco.cc/key-papers/paper-aggarwal-plasma-genotyping-personalised-therapy-jama-oncol-2019/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1001/jamaoncol.2018.4305>, <https://pubmed.ncbi.nlm.nih.gov/30325992/> ;
  schema:sameAs <https://doi.org/10.1001/jamaoncol.2018.4305> ;
  schema:datePublished "2019"^^xsd:gYear ;
  schema:author "Aggarwal C, Thompson JC, Black TA, et al." ;
  onco:cancers <https://onco.cc/cancers/nsclc/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/cgp/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/alk/>, <https://onco.cc/targets/met/>, <https://onco.cc/targets/ros1/>, <https://onco.cc/targets/ret/>, <https://onco.cc/targets/her2/>, <https://onco.cc/targets/braf/> ;
  onco:pathways <https://onco.cc/pathways/rtk-activation/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/cfdna/>, <https://onco.cc/terms/ngs/>, <https://onco.cc/terms/biopsy/> ;
  onco:journals <https://onco.cc/journals/jama-oncology/> .